Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377014906> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W4377014906 endingPage "12S" @default.
- W4377014906 startingPage "12S" @default.
- W4377014906 abstract "INTRODUCTION: Fezolinetant was well tolerated and effective in reducing the frequency and severity of menopause-associated, moderate-to-severe vasomotor symptoms (VMSs) in SKYLIGHT 1 and 2. This analysis investigated the relationship between intrinsic (individual-related) and extrinsic (outside-influence) factors and fezolinetant efficacy. METHODS: In these phase 3, double-blind, placebo-controlled, IRB-approved studies (NCT04003155 and NCT04003142), women aged 40 through 65 years with moderate-to-severe VMSs (seven or more hot flushes/day) were randomized to once-daily placebo, fezolinetant 30 mg, or fezolinetant 45 mg. For this pooled analysis, the influence of intrinsic and extrinsic factors on change from baseline to week 12 in the frequency of moderate-to-severe VMSs was assessed by subgroups using a mixed model for repeated measurement. RESULTS: One thousand twenty-two women took one or more dose (placebo, n=342; fezolinetant 30 mg, n=339; fezolinetant 45 mg, n=341). Consistent improvements in VMS frequency over placebo were observed across subgroups with fezolinetant 45 mg. For intrinsic factors, least-square mean differences (95% CI) between fezolinetant 45 mg and placebo were as follows: age less than 55 years, −2.78 (−3.74, −1.82); 55 years or older, −2.24 (−3.23, −1.24); White race, −2.17 (−2.93, −1.41); Black race, −3.67 (−5.32, −2.01); and body mass index of 30 kg/m 2 or higher, −2.87 (−4.11, −1.63). Extrinsic factors showed the following differences: current smoker, −3.48 (−5.19, −1.77); former/never smoker, −2.32 (−3.08, −1.57); European resident, −1.50 (−2.73, −0.26); and North American resident, −2.95 (−3.78, −2.13). Similar efficacy trends were observed with fezolinetant 30 mg. CONCLUSION: Fezolinetant was efficacious in treating moderate-to-severe VMSs associated with menopause across the intrinsic and extrinsic factors investigated, demonstrating its potential utility in a broad population." @default.
- W4377014906 created "2023-05-19" @default.
- W4377014906 creator A5023094810 @default.
- W4377014906 creator A5023211835 @default.
- W4377014906 creator A5041234392 @default.
- W4377014906 creator A5044102386 @default.
- W4377014906 creator A5061212683 @default.
- W4377014906 creator A5069339514 @default.
- W4377014906 date "2023-05-01" @default.
- W4377014906 modified "2023-10-18" @default.
- W4377014906 title "Fezolinetant Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause: Effect of Intrinsic and Extrinsic Factors in Two Phase 3 Studies [ID: 1356963]" @default.
- W4377014906 doi "https://doi.org/10.1097/01.aog.0000929848.45312.e5" @default.
- W4377014906 hasPublicationYear "2023" @default.
- W4377014906 type Work @default.
- W4377014906 citedByCount "0" @default.
- W4377014906 crossrefType "journal-article" @default.
- W4377014906 hasAuthorship W4377014906A5023094810 @default.
- W4377014906 hasAuthorship W4377014906A5023211835 @default.
- W4377014906 hasAuthorship W4377014906A5041234392 @default.
- W4377014906 hasAuthorship W4377014906A5044102386 @default.
- W4377014906 hasAuthorship W4377014906A5061212683 @default.
- W4377014906 hasAuthorship W4377014906A5069339514 @default.
- W4377014906 hasConcept C126322002 @default.
- W4377014906 hasConcept C142724271 @default.
- W4377014906 hasConcept C204787440 @default.
- W4377014906 hasConcept C27081682 @default.
- W4377014906 hasConcept C2776214587 @default.
- W4377014906 hasConcept C2778562196 @default.
- W4377014906 hasConcept C2780221984 @default.
- W4377014906 hasConcept C71924100 @default.
- W4377014906 hasConceptScore W4377014906C126322002 @default.
- W4377014906 hasConceptScore W4377014906C142724271 @default.
- W4377014906 hasConceptScore W4377014906C204787440 @default.
- W4377014906 hasConceptScore W4377014906C27081682 @default.
- W4377014906 hasConceptScore W4377014906C2776214587 @default.
- W4377014906 hasConceptScore W4377014906C2778562196 @default.
- W4377014906 hasConceptScore W4377014906C2780221984 @default.
- W4377014906 hasConceptScore W4377014906C71924100 @default.
- W4377014906 hasIssue "5S" @default.
- W4377014906 hasLocation W43770149061 @default.
- W4377014906 hasOpenAccess W4377014906 @default.
- W4377014906 hasPrimaryLocation W43770149061 @default.
- W4377014906 hasRelatedWork W1985458017 @default.
- W4377014906 hasRelatedWork W2002305772 @default.
- W4377014906 hasRelatedWork W2008426008 @default.
- W4377014906 hasRelatedWork W2011220060 @default.
- W4377014906 hasRelatedWork W2060589574 @default.
- W4377014906 hasRelatedWork W2412493536 @default.
- W4377014906 hasRelatedWork W2473183365 @default.
- W4377014906 hasRelatedWork W2524137636 @default.
- W4377014906 hasRelatedWork W2902388361 @default.
- W4377014906 hasRelatedWork W3164736496 @default.
- W4377014906 hasVolume "141" @default.
- W4377014906 isParatext "false" @default.
- W4377014906 isRetracted "false" @default.
- W4377014906 workType "article" @default.